1332 Objectives To investigate the regulation effect of the β-adrenoceptor (ADRB) activity to
the levels of GLUT-1 and HK-2, which are related to the glucose uptake, and clarify its …

The advancement of breast cancer therapy is limited by the biologic behaviors of cancer
cells, such as metastasis and recurrence. β-adrenoceptors (ADRB) are reported to be …

Purpose The aim of the study was to non-invasively evaluate the anticancer activity of a
traditional Chinese medicine—Huaier, combined with paclitaxel (PTX) in breast cancer …

Objective: To investigate the value of 18F-FDG total-body PET/CT dynamic imaging in
evaluating the efficacy of early radiotherapy for MDA-MB-231 breast cancer bearing nude …

1216 Objectives The β3-adrenoreceptor (β3-A) on brown adipose tissue (BAT) is known as
a regulator of glucose metabolism. Here, we report the evaluation of two β3-A agonists …

181 Objectives Hormonal receptor status plays an important role to set up the therapeutic
strategy for breast cancer patients. The purpose of this study was to investigate whether …

1285 Objectives: PET imaging with 18 F-fluorodeoxyglucose (FDG) is used clinically for
initial staging, restaging, and assessing therapy response in breast cancer. Tumor FDG …

Objective To establish the acquired tamoxifen (TAM)-resistant human breast cancer cell line
T47D-TamR, compare the 18F-FDG uptake rate between T47D-TamR and its parental cell …

Abstract Introduction 18 F-2-deoxy-2-fluoro-d-glucose (18 F-FDG) positron emission
tomography (PET) has been used for imaging human cancers for several decades. Despite …

1448 Objectives Anti-angiogenic therapy (AAT) is now widely-used clinic anticancer strategy
by blocking the oxygen and nutrient supply to starve cancer cells. Herein, we aimed to …